BPA Call 36C24221A0005-36C24224N0144

Award Date 10/4/23
Potential Completion Date 9/30/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Norcross, GA, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a $15,583 firm fixed price blanket purchase agreement call contract to Immucor Inc. to deliver blood bank reagents. Immucor will supply these immunology diagnostic test reagents to VA facilities in Veterans Integrated Service Network 2 under the terms of their existing GSA Schedule 65-VII contract for invitro diagnostics, reagents, and tests. The one year contract runs from October 2023 through September 2024 for...
The Department of Veterans Affairs Veterans Health Administration awarded a $18,000 firm fixed price blanket purchase agreement call contract to Immucor Inc. to provide blood bank reagents for its Veterans Integrated Service Network 2 region. Immucor will deliver immunohematology diagnostic test kits and supplies for blood banking purposes under the one year contract running from October 2023 through September 2024. Funding is provided through the VHA and performance will take place in Norcross,...
The Department of Veterans Affairs Veterans Health Administration awarded a $2,536.56 firm-fixed-price blanket purchase agreement call contract to Immucor Inc. to provide blood bank reagents. Immucor will deliver the reagents to support VHA's Veterans Integrated Service Network 2 located in Norcross, Georgia. The contract was awarded under Immucor's GSA Schedule 65-VII for invitro diagnostics, reagents, and tests. This schedule, administered by the General Services Administration, provides...
This federal contract award to Immucor Inc. is for the provision of reagents for the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 10. The contract has a potential value of $244,967.85 and is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call issued under Immucor's General Services Administration (GSA) Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits. Immucor, as a manufacturer of goods, has...
Immucor Inc. was awarded a $18,963.82 firm fixed price blanket purchase agreement call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to provide blood bank reagents and consumables under GSA Schedule 65-VII: In Vitro Diagnostics, Reagents, Tests. The contract has a period of performance through March 31, 2024 to deliver the requested blood bank reagents to support healthcare operations. No set-aside provisions were applied...
This federal contract award to Immucor Inc. is for the provision of blood bank reagents to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The contract has a potential value of $18,143.71 and a completion date of March 31, 2025. The contract is a Blanket Purchase Agreement (BPA) call against Immucor's existing General Services Administration (GSA) Multiple Award Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits. Immucor,...
Immucor Inc. was awarded a $82,273.64 firm fixed price blanket purchase agreement call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to deliver blood bank reagents and consumables. The contract was awarded on April 1, 2023 under the General Services Administration Schedule 65-VII for invitro diagnostics, reagents, and tests, with an anticipated completion date of March 31, 2024. The contract has no set-aside designation and...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call under the General Services Administration (GSA) Multiple Award Schedule contract for In Vitro Diagnostics, Reagents, Test (FSS-65-VII), awarded to Immucor Inc. by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 6. The contract, valued at $53,174.88, is for the delivery of blood bank reagents and quality control materials to support the VA's blood banking operations. As a provider of automated...
This is a federal contract award to Immucor Inc., a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The contract, valued at $122,621.21, is for the delivery of BLOOD BANK REAGENTS to the Veterans Integrated Service Network 4 (VISN 4), a civilian agency of the U.S. Department of Veterans Affairs. The contract is a Blanket Purchase Agreement (BPA) call issued under Immucor's existing General Services...
This is a firm-fixed-price contract award to Immucor Inc. for the provision of blood bank reagents to the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 17. The contract has a ceiling value of $20,186.69 and an ultimate completion date of July 31, 2024. The contract was awarded on August 1, 2023 and is a call against Immucor's General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. Immucor is a...

The Department of Veterans Affairs Veterans Health Administration awarded a $15,440.88 firm fixed price blanket purchase agreement call contract to Immucor Inc. to provide blood bank reagents. Immucor will deliver the reagents to support VHA's Veterans Integrated Service Network 2, which coordinates health care services for veterans across multiple medical centers in parts of Georgia and South Carolina. The contract was awarded against Immucor's existing GSA Schedule 65 - In Vitro Diagnostics, Reagents, Test vehicle, with performance taking place in Norcross, Georgia over the one-year period from October 2023 through September 2024. No set aside designation was specified.

Generated 12/24/23, 10:20 PM